ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,282.00
      -0.27%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.135
      -0.25%
      Bitcoin
      63,201.55
      0.40%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axsome Therapeutics Inc (AXSM)

      7. Axsome Therapeutics Inc (AXSM) News

      AXSM

      Axsome Therapeutics (AXSM)

      Axsome Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXSM
      DateTimeSourceHeadlineSymbolCompany
      09/04/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      09/04/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of MigraineNASDAQ:AXSMAxsome Therapeutics Inc
      08/27/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Participate in Investor Conferences in SeptemberNASDAQ:AXSMAxsome Therapeutics Inc
      08/21/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      08/21/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.NASDAQ:AXSMAxsome Therapeutics Inc
      08/09/20247:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      08/09/20245:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      08/05/20244:36PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXSMAxsome Therapeutics Inc
      08/05/20244:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXSMAxsome Therapeutics Inc
      08/05/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      08/05/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AXSMAxsome Therapeutics Inc
      08/05/20245:46AMIH Market NewsU.S. Index Futures and Oil Prices Plunge on Recession ConcernsNASDAQ:AXSMAxsome Therapeutics Inc
      07/11/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5NASDAQ:AXSMAxsome Therapeutics Inc
      06/11/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      06/11/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      06/05/20247:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXSMAxsome Therapeutics Inc
      06/05/20247:35AMGlobeNewswire Inc.Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem LaboratoriesNASDAQ:AXSMAxsome Therapeutics Inc
      06/04/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness MonthNASDAQ:AXSMAxsome Therapeutics Inc
      06/03/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Supports Alzheimer’s & Brain Awareness MonthNASDAQ:AXSMAxsome Therapeutics Inc
      05/30/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20248:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20248:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20244:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20244:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/29/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024NASDAQ:AXSMAxsome Therapeutics Inc
      05/28/20244:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXSMAxsome Therapeutics Inc
      05/28/20247:00AMGlobeNewswire Inc.Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) MeetingNASDAQ:AXSMAxsome Therapeutics Inc
      05/08/20247:00AMGlobeNewswire Inc.Axsome Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:AXSMAxsome Therapeutics Inc
      05/06/20245:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXSMAxsome Therapeutics Inc
      05/06/20248:09AMIH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:AXSMAxsome Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:AXSM